Current Issue Article Reprints

Vol. 4, No. 4
December 2006

Article reprints are provided as a service to oncology profressionals as part of the Advances in Targeted Cancer Therapies website (www.targetedtherapies.org). Reprints are not for commercial distribution.

slides

Angiogenesis Inhibition: A Targeted Approach to Cancer Therapy

Presentation: (10) Slides, notes and references included
File name: atct02_2004.ppt [1.9 MB]

View entire presentation

Download Slides

The notion that cancer might be slowed or halted by blocking the vasculature that nourishes a tumor has been studied for decades with frustratingly little success. Recent advances, however, have finally resulted in the clinical development of several classes of promising angiogenesis inhibitors. This slide set reviews the angiogenic mechanisms that constitute targets for this approach to cancer therapy and outlines how the various agents in development exert their effects. Any or all of these slides may be used by oncology professionals to enhance and customize educational and informational presentations on angiogenesis inhibition.

The Epidermal Growth Factor Receptor as a Target for Cancer Therapy

Presentation: (7) Slides, notes and references included
File name: atct01_2003.ppt [2.0 MB]

View entire presentation

Download Slides

Inhibition of the epidermal growth factor receptor (EGFR) is currently a therapeutic strategy of keen interest in oncology. Many tumor types express or overexpress EGFR. A growing number of compounds, both antibodies and small molecules, have been developed to target various points along the EGFR pathway. In the interests of helping clinicians understand the biology and mechanisms of this novel approach to cancer therapy, this slide set represents a visual primer that may be used to enhance and customize educational and informational presentations on EGFR inhibition.